Skip to content
Dose Brief
Menu
No. 170 here · Grade C

Edessa review

Clean three-rung tables one click in, behind a front page whose three cards all quote six-month rungs and whose cheapest belongs to a different drug.

Visit Edessa Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$179/mo month-to-month injectable (compounded)
Tirzepatide
$239/mo month-to-month (compounded)
Coverage
Not published
Brand-name
Compounded only

Prices read from Edessa's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 13 September 2026, read live off the provider's own pages that day rather than taken on trust. There is no earlier reading here to compare against, so the direction is "new" rather than stable — a first observation is not a trend. The gap to watch is between the two surfaces: the front page quotes $135, $199 and $209 while the product pages behind them quote $179, $229 and $239 for the same three products month to month.

The scorecard

Edessa scored on our six Brief Score factors. See the methodology.

Price Stability64/100
Supply Reliability72/100
Transparency66/100
Access Breadth82/100
Clinical Oversight72/100
Track Record66/100

What we like

  • Each product page carries a plain three-rung table, so the commitment behind every figure is visible
  • "Same price, every dose" is printed on each product page
  • Names its operating entity and a full street address in Las Vegas, Nevada
  • All-inclusive — consultation, medication, free expedited shipping, ongoing check-ins and 24/7 support — and HSA and FSA eligible

The caveats

  • The front page leads with "Start for just $135", a six-month prepay on the semaglutide injection
  • All three front-page cards quote the six-month rung, so the real monthly rates appear only after a click
  • Its Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation"
  • "Join 100,000+ successful GLP-1 patients" carries no source, and the money-back guarantee's terms are on no marketing page

The brief

Best for: A six-month committer, or a reader willing to click past the front page to the table with the real monthly rate. Clean three-rung tables one click in, behind a front page whose three cards all quote six-month rungs and whose cheapest belongs to a different drug.

Ranked #170 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Edessa.

Closest here

The providers scoring nearest Edessa — the realistic shortlist if you're weighing it.

Weighing Edessa against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Edessa, and every provider that outranks it is listed on the Edessa alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Edessa's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Edessa's site. Not medical advice; see our disclosure.

← Back to all rankings